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Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for
Host Mucosal Glycans
Nicholas A. Pudlo,a Karthik Urs,a Supriya Suresh Kumar,a J. Bruce German,b David A. Mills,c Eric C. Martensa
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USAa; Department of Food Science and Technology,
University of California, Davis, Davis, California, USAb; Department of Viticulture and Enology, University of California, Davis, Davis, California, USAc
ABSTRACT Many symbiotic gut bacteria possess the ability to degrade multiple polysaccharides, thereby providing nutritional
advantages to their hosts. Like microorganisms adapted to other complex nutrient environments, gut symbionts give different
metabolic priorities to substrates present in mixtures. We investigated the responses of Bacteroides thetaiotaomicron, a common
human intestinal bacterium that metabolizes more than a dozen different polysaccharides, including theO-linked glycans that
are abundant in secreted mucin. Experiments in which mucin glycans were presented simultaneously with other carbohydrates
show that degradation of these host carbohydrates is consistently repressed in the presence of alternative substrates, even by
B. thetaiotaomicron previously acclimated to growth in pure mucin glycans. Experiments with media containing systematically
varied carbohydrate cues and genetic mutants reveal that transcriptional repression of genes involved in mucin glycanmetabo-
lism is imposed by simple sugars and, in one example that was tested, is mediated through a small intergenic region in a
transcript-autonomous fashion. Repression of mucin glycan-responsive gene clusters in two other human gut bacteria, Bacte-
roides massiliensis and Bacteroides fragilis, exhibited variable and sometimes reciprocal responses compared to those of
B. thetaiotaomicron, revealing that these symbionts vary in their preference for mucin glycans and that these differences occur at
the level of controlling individual gene clusters. Our results reveal that sensing andmetabolic triaging of glycans are complex
processes that vary among species, underscoring the idea that these phenomena are likely to be hidden drivers of microbiota
community dynamics andmay dictate which microorganisms preferentially commit to various niches in a constantly changing
nutritional environment.
IMPORTANCE Human intestinal microorganisms impact many aspects of health and disease, including digestion and the pro-
pensity to develop disorders such as inflammation and colon cancer. Complex carbohydrates are a major component of the in-
testinal habitat, and numerous species have evolved and refined strategies to compete for these coveted nutrients. Our findings
reveal that individual bacteria exhibit different preferences for carbohydrates emanating from host diet andmucosal secretions
and that some of these prioritization strategies are opposite to one another. Thus, we reveal new aspects of how individual bacte-
ria, some with otherwise similar metabolic potential, partition to “preferred niches” in the complex gut ecosystem, which has
important and immediate implications for understanding and predicting the behavioral dynamics of this community.
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Bacteria in the human colon have developed several strategiesto forage the complex carbohydrates (polysaccharides or gly-
cans) present in dietary fiber. With the exception of starch, mem-
bers of this diverse group of nutrients transit the proximal intes-
tine undigested due to a lack of appropriate human enzymes.
Residual dietary glycans therefore require the activity of symbiotic
bacteria in the distal gut first for hydrolysis (1) and then for fer-
mentation into host-absorbable short-chain fatty acids, which
provide a significant contribution to our dietary energy harvest
(2). Human intestinal cells also secrete endogenous glycans,
largely as mucin glycoproteins and epithelial glycocalyx, which
contribute to a protective barrier for host tissue. Most glycans
associated with intestinal mucins areO-linked glycans (herein re-
ferred to as O-glycans) to the side chains of serine and threonine
residues inmucin polypeptides. Encompassing ~102 different lin-
ear and branched structures, the O-glycans that are attached to
mucins are remarkably diverse and also distinct from dietary fiber
glycans (3, 4). Thus, to metabolizeO-glycans, gut bacteria require
highly diversified sensory systems coupled to expression of dozens
of appropriate enzymes (5, 6).
A number of species from the dominant human gut bacterial
phyla (Bacteroidetes, Firmicutes, Actinobacteria, and Verrucomi-
crobia) have been associated with degradation ofmucus and/or its
attached O-glycans, while other species in these phyla lack this
behavior (7–11). Several experiments with simplified or trans-
planted gut microbial communities assembled in gnotobiotic
mice have implied that the ability to forage host-derived glycans
provides a metabolic alternative when dietary glycans wane or are
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absent or when microorganisms are forced into competition by
the addition of additional microbial species (12–17).
Detrimental host effects associated with disrupted mucin gly-
cosylation and bacterial degradation of host glycan structures are
beginning to emerge as well. Studies usingmousemodels that lack
normal mucin expression or glycosylation have observed sponta-
neous colonic inflammation or increased susceptibility to inflam-
matory agents, including individual bacteria (18–21), raising the
possibility that microbe-catalyzed alterations to mucus could also
be harmful. This notion is supported by findings in humans with
ulcerative colitis, which show that O-glycosylation patterns are
simpler in people with active disease versus the same patients dur-
ing remission (22). Symbionts such as Bacteroides thetaiotaomi-
cron can liberate sialic acid fromhost glycoconjugates, providing a
sugar that it cannot use itself to pathogens such as Salmonella
enterica and Clostridium difficile (23). Finally, a recent study in-
volving mice that are genetically susceptible to acute colonic in-
flammation that can be induced by B. thetaiotaomicron or other
commensal Bacteroidetes demonstrated that genetic disruption of
bacterial sulfatase production blocks the progression of disease
(24). The precise, disease-causing target(s) of B. thetaiotaomicron
sulfatases has not yet been identified. However, the observation
thatmost of the 28 different predicted sulfatase-encoding genes in
the colitogenic B. thetaiotaomicron type strain (25) are contained
in gene clusters that are responsive to host mucin O-glycans or
glycosaminoglycans (6, 24) suggests that bacterial interactions
with the sulfated carbohydrates abundant in colonicmucus or the
glycocalyx are a critical step.
B. thetaiotaomicron and several other mucin-degrading Bacte-
roides species possess the ability to catabolize other carbohydrates
in addition toO-glycans. To date, essentially all of thesemetabolic
abilities that have been described aremediated by tightly regulated
expression of corresponding polysaccharide utilization loci
(PULs) that encode specific degradative machinery for the partic-
ular substrate(s) present (7).We have previously shown that when
B. thetaiotaomicron is grown in a mixture containing a dozen dif-
ferent glycans, it represses expression of genes involved in
O-glycan utilization until the latest stages of growth whenmost or
all of the other substrates have been depleted (26). Here, we inves-
tigate the ability of individual glycans to modulate O-glycan me-
tabolism in B. thetaiotaomicron and other gut species and provide
molecular genetic insight into the basis of this phenomenon. We
identify two species, Bacteroides massiliensis and Bacteroides fragi-
lis that exhibit different, often reciprocal, O-glycan preferences
compared to those of B. thetaiotaomicron. Given the likelihood
that such metabolic variations extend to other nutrients, the phe-
nomena described here represent an underappreciated and per-
haps pivotal driver of dynamics in the diet-microbiota-host rela-
tionship.
RESULTS
O-linked glycans are given low metabolic priority by
B. thetaiotaomicron. Themetabolic preferences and correspond-
ing regulatory mechanisms exhibited by symbiotic bacteria in the
human colon remain largely unexplored. We previously found
that B. thetaiotaomicron preferentially metabolizes glycosamino-
glycans prior to O-glycans when they are present together in a
mixture (6). To test the hypothesis that other glycans repress
O-glycan use, we grew B. thetaiotaomicron in pairwise mixtures of
porcine mucin O-glycans (PMOG) and several other carbohy-
drates (Fig. 1). If either substrate was prioritized, we anticipated
“diauxic” growth patterns, indicatingmetabolic shifts between the
most- and least-preferred nutrients. In addition, we harvested
bacterial RNA at “early” and “late” points in growth and com-
pared glycan-specific PUL expression by quantitative PCR
(qPCR) on reverse-transcribed RNA.
Data for a plant cell wall pectin (homogalacturonan), a bacte-
rial 2,6-linked fructan capsule (levan), and an animal tissue gly-
cosaminoglycan (chondroitin sulfate) are shown in Fig. 1A to H.
Consistent with our hypothesis, we observed diauxic growth in
which the early growth phase was prolonged by increasing ho-
mogalacturonan, levan, or chondroitin sulfate (Fig. 1A,D, andG).
Gene expression comparisons further support repression of
O-glycan metabolism with high expression of sentinel susC-like
genes from the homogalacturonan, levan, and chondroitin sulfate
PULs early and reciprocal patterns for nearly all of the seven dif-
ferentO-glycan-responsive PULs that were tested (Fig. 1B, E, and
H; see Fig. S1I in the supplemental material). In addition,
B. thetaiotaomicron cells that were pregrown in PMOG abruptly
repressed O-glycan PULs when homogalacturonan, levan, or a
mixture of all glycans used was introduced (Fig. 1C and F;
Fig. S2A).
Results similar to those with homogalacturonan, levan, and
chondroitin sulfate were observed with nearly all other glycans
tested (see Fig. S1A to S1H in the supplemental material). In
aggregate, gene expression trends for glycans tested against
PMOG revealed significant overall repression of O-glycan genes,
underscoring that utilization of this host-derived nutrient is low
in B. thetaiotaomicron’s metabolic hierarchy (Fig. 1I). Although B.
thetaiotaomicron growth rates on PMOG are among the lowest
compared to other glycans (Fig. 1J; see Fig. S3 for schematics of all
glycans used), strong repression of O-glycan PULs in mixtures
with levan or heparin, which both had similarly low growth rates,
argues that growth rate is insufficient to account for this trend.
Only dextran failed to exhibit significant expression changes be-
tween early and late growth (blue data points in Fig. 1I), although
it still elicited a diauxic growth profile (Fig. S1C).
To determine whether the signals that induce repression of
O-glycan PULs originate from the transcriptional sensor/regula-
tors that activate expression of their cognate PULs in response to
the alternative glycans that were presented with PMOG, as was
reported in one previous study (27), or their component simple
sugars, we performed experiments with the monosaccharides
fructose and galactose. Fructose is the sole component of levan
and is sufficient to trigger expression of the single levan PUL (28).
Galactose is abundant in both pectic galactan and PMOG (6). The
presence of either monosaccharide was sufficient to repress ex-
pression of O-glycan PULs (Fig. 1K and L). The observation that
galactose decreases expression of O-glycan PULs reveals that a
monosaccharide, in sufficient quantity, is capable of suppressing
utilization of another polymer in which it is also contained.More-
over, activation of the repressing glycan’s cognate PUL, via its
associated regulator, is not required because galactose does not
induce expression of the pectic galactan PUL (Fig. 1L). Additional
monosaccharide experiments further support the idea that simple
sugars mediate repression, albeit with notable variation with re-
spect to sugar identity and timing (see Fig. S2B to S2L in the
supplemental material).
Finally, we grew B. thetaiotaomicron on mixtures containing
human milk oligosaccharides (HMOs), glycans with structural
Pudlo et al.
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FIG1 B. thetaiotaomicron deprioritizesO-glycanmetabolism in the presence of competing glycans andmonosaccharides. (A)B. thetaiotaomicron growth curves
in mixtures of homogalacturonan (HG) and PMOG. The dashed horizontal lines indicate the pause in exponential growth that occurs as a function of changing
glycanmix concentrations. (B) Relative expression differences between early and late growth phases forB. thetaiotaomicron grown in amixture ofHGandPMOG
(1.5 mg/ml and 7 mg/ml, respectively). Early and late samples were harvested before and after the pause, respectively. A total of seven previously identified
O-glycan-responsive PULs (6) were monitored for changes in expression based on the criteria that they were inducedmore than 8.5-fold in pure PMOG and are
not part of recombinational shufflons that might obfuscate temporal expression. PULs with statistically significant (P  0.05 by one-tailed Student’s t test)
increases in expression during early growth, PULs with statistically significant increases in later growth, and PULs with no significant changes in early versus late
growth are shown. (C) A “spike-in” experiment in whichB. thetaiotaomicronwas grown tomid-exponential phase on 10mg/ml PMOGalone and thenHG (final
concentration of 2.5 mg/ml) was abruptly introduced. Bacterial samples were harvested at 30-, 60-, 90-, and 120-min intervals after the introduction of HG. A
corresponding negative control (minimal medium with no carbon) was used to monitor changes in O-glycan PUL expression (gray bars). Expression changes
were determined relative to the culture grown in PMOG only (time zero [T0]). (D to H) Experiments similar to those described above, but with levan or
chondroitin sulfate (CS) as the competing glycan. Additional experiments for pairwise combinations are shown in Fig. S1 in the supplemental material. (I)
(Continued)
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similarity toO-glycans, plus either homogalacturonan or levan to
determine whether O-glycan/HMO-responsive PULs are re-
pressed. Both of these substrate pairs elicited clear diauxic growth
(see Fig. S4A and S4B in the supplemental material) and repres-
sion of knownHMOutilization geneswhenmixedwith levan (11)
(Fig. 1M).
Expression of some O-glycan utilization functions in other
Bacteroides species is opposite that in B. thetaiotaomicron. In
seven other B. thetaiotaomicron strains with 98% 16S rRNA
genes identity to the type strain VPI 5482, we observed preferred
use of fructans, either levan or inulin (chosen based on which
linkage type each strain optimally used), and homogalacturonan
when individuallymixedwith PMOG (see Fig. S4C and S4D in the
supplemental material). This commonality among B. thetaiotao-
micron strains raises the question of whether more distantly re-
lated gut symbionts also behave similarly and assign lowmetabolic
priority to O-glycans when they are presented with alternative
polysaccharides. Thus, we investigated two other O-glycan-
degrading species, Bacteroides massiliensis and Bacteroides fragilis,
with various phylogenetic distances relative to B. thetaiotaomicron
(Fig. S5A). A survey of the glycans that these two species can use as
the sole carbon source revealed that, among the substrates tested,
they are restricted to PMOG and starch (B. massiliensis), and
PMOG, starch, and inulin (B. fragilis), respectively (see Table S1 in
the supplemental material). Transcriptome sequencing
(RNAseq)-based whole-genome transcriptional profiling identi-
fied 6 of 33 PULs in B.massiliensis and 8/52 PULs in B. fragilis that
are active onPMOG(Tables S2 and S3). A genome survey revealed
that B.massiliensis has a PUL with identical organization to the B.
thetaiotaomicron starch utilization system (sus) and is activated on
starch (Fig. S5B and S5C). Likewise, B. fragilis has two previously
described PULs thatmediate starch and inulin utilization (28, 29).
Growth of B. massiliensis in a mixture of PMOG and starch
failed to reveal a distinct diauxic pattern as clear as that observed
for B. thetaiotaomicron. However, two short pauses in late growth
suggested a possible metabolic shift (Fig. 2A) that was supported
by individual growth levels on PMOG and starch when tested
alone (see Fig. S5F in the supplemental material). Early versus late
expression measurements revealed that B. massiliensis represses
starch utilization until later growth and exhibits neutral or pre-
ferred expression of five of the six O-glycan-responsive PULs
tested (Fig. 2B). Despite B. fragilis exhibiting diauxic growth pat-
terns that appeared to favor either starch or inulin over PMOG
(Fig. S5G and S5H), the PULs for these two glycans did not show
preferential expression at the growth points analyzed (Fig. 2C and
E). In contrast, some O-glycan-responsive PULs were prioritized
in early growth, while others remained neutral or were activated
later (Fig. 2D and F). The latter finding highlights that indepen-
dent gene clusters, which otherwise are activated by related gly-
cans from the same source (here, those present in gastric mucin)
can exhibit opposing behavior. This observation suggests that
these PULs are individually regulated by opposing signals that
vary in their influence on overall expression. These signals likely
emanate from both positive and negative cues: recognition of the
cognate glycan or repression in the presence of other glycans/
sugars, respectively. The contributions of these opposing forces
are considered further below.
Differential substrate recognition in complexmixtures con-
tributes to prioritized PUL expression.The above results suggest
that simple sugarsmediate substantial repression ofO-glycanme-
tabolism (Fig. 1K and L), similar to 3=-5= cyclic AMP (cAMP)
catabolite repression in Escherichia coli and Bacillus subtilis (30).
However, no evidence for cAMP-responsive pathways has been
reported in Bacteroides species (31), and we also failed to observe
decreased repression of O-glycan-targeting PULs with the addi-
tion of cAMP (see Fig. S6A in the supplemental material). We
concluded that the presence of polysaccharide surface capsule,
which is both phase variable and a known barrier to incoming
glycan nutrients (32), is not required for repression of O-glycan
PULs under the conditions tested (Fig. S6B). Finally, experiments
with a mutant that is unable to utilize levan (BT1754) revealed
that the mere presence of this preferred glycan in the extracellular
environment of a strain that cannot degrade it is insufficient to
trigger repression of genes involved inO-glycan use (Fig. S6C and
S6D). Collectively, these results lead us to conclude that a cAMP-
independent repression mechanism exists in Bacteroides that is
not passively governed by the presence of bacterial or environ-
mental polysaccharides at the cell surface.
To begin to understand the mechanism(s) underlying B.
thetaiotaomicron’s prioritization of different glycans, we chose to
separate the glycan-sensing capacity of PULs with different re-
sponses to O-glycans from their corresponding regulatory ele-
ments. To do this, we created two chimeric PULs that were recom-
bined just downstream of their predicted Ton box sequences
(Fig. 3A and B; see Fig. S6E in the supplemental material). One of
the O-glycan PULs that was chosen for this recombination (ge-
netic locus from BT4355 to BT4359 [BT4355-59]) wasmost active
during early growth in previous experiments with a partially de-
fined mixture ofO-linked glycans and glycosaminoglycans that is
termed the “100 mM fraction” (6) based on how it is purified (see
Fig. S7A to S7C and the corresponding legend in the supplemental
material for details). This same PUL was also weakly and incon-
sistently repressed in the pairwise glycan mixtures shown in Fig. 1
and Fig. S1. In contrast, the other PUL (BT4636-31) showed re-
ciprocal expression during multiphasic growth in the 100 mM
fraction (Fig. 3C) and also tended to bemore strongly repressed in
the pairwise mixtures.
The extracytoplasmic function sigma factor (ECF-)/anti-
factor pairs that regulate these PULs work with outer membrane
TonB-dependent transporters via a mechanism termed trans-
envelope signaling (33). In this sensory strategy, outer membrane
transporters recognize glycans during passage across the outer
Figure Legend Continued
Aggregate expression differences of all PULs involved in metabolizing O-glycans and the non-O-glycans tested. Each symbol shows the value for one separate
biological replicate of three conducted for each combination. (J) Exponential growth rates of B. thetaiotaomicron on all individual glycans tested. PG, pectic
galactan; AP, amylopectin; AG, arabinogalactan; RG I, rhamnogalacturonan I. (Letters over each bar indicate data groupings in which the t test P values were
0.001). (K and L) Additional early/late growth phase experiments comparing the responses to a competing polysaccharide (levan and pectic galactan) and their
corresponding monosaccharides (fructose and galactose). (M) HMO-responsive PUL (11) expression during early and late growth in a mixture of levan and
humanmilk oligosaccharides (HMOs). A total of three biological replicates were conducted for each experimental condition, including bacterial growth curves.
All values are means standard deviations (SD) (error bars), except in panels C and F, where they are means standard errors (SE) (error bars).
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membrane (illustrated as stars in Fig. 3B), and this information is
relayed to the corresponding ECF--dependent promoters via
protein contacts between the N-terminal domain of the outer
membrane transporter, inner membrane anti- factor, and cyto-
plasmic ECF- factor (5). Since all of these protein domains are
encoded upstream of the Ton box recombination sites, our chi-
meric PULs were designed to separate the regulatory elements
from the downstream regions of the susC-like genes that encode
glycan-sensing transporter domains (Fig. 3B). Despite their dis-
cordant responses in the 100 mM fraction, these PULs are both
activated on PMOG and N-acetyllactosamine (LacNAc), a major
disaccharide building block of O-glycans, as the sole carbon
source, suggesting that they respond to similar ligands that may
share overlapping structural features (see Fig. S7D in the supple-
mental material).
Both chimeric PULs were activated during growth on
O-glycans as the sole carbon source, suggesting that chimeric re-
combination did not eliminate their function (see Fig. S7E in the
supplemental material). We then grew wild-type B. thetaiotaomi-
cron and a strain that simultaneously contained both chimeric
PULs in place of the wild-type loci in the 100 mM fraction that
produces discordant phase-specific PUL expression (Fig. 3C). In-
terestingly, the susC-like genes in the chimeric PULs, which were
uncoupled from their native regulatory regions, exhibited discor-
dant growth between early and late growth phases that matched
the pattern observed for wild-type B. thetaiotaomicron. A gene
from a control PUL (BT3332), which mediates high-priority
chondroitin sulfate catabolism (6), did not show altered phase-
specific expression in the chimeric strain. This observation indi-
cates that the regulatory components of these two PULs do not
mediate expression differences in this particular case, instead the
differential sensing of nutrients via the outer membrane TonB-
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dependent transporter causes this behavior. Despite the fact that
these two PULs show responses to similar O-glycan saccharides,
such as LacNAc, this behavior could be explained by the sequential
release of recognizable saccharides frommore-complex structures
present in the 100 mM mixture that drive the selective and se-
quential activation of the two PULs monitored during growth in
this mixture. In contrast, if promoter level regulatory events, such
as those mediated by cAMP receptor protein (CRP)-cAMP com-
plexes during catabolite repression in other bacteria, predominate
in this system, we would have expected growth phase-dependent
expression changes to track with each PUL’s respective promoter
and regulator-encoding genes instead of with susC-like sensor/
transport regions.
Atranscribed intergenic regionmediates conditional repres-
sion of one O-glycan PUL. In considering additional transcrip-
tional mechanisms that couldmediate repression ofO-glycan uti-
lization, we noted that six of seven O-glycan PULs that were
repressed in Fig. 1 are controlled by ECF- factor/anti- protein
pairs (5), and the genes encoding anti- factors and downstream
TonB-dependent (SusC-like) receptors are separated by some-
times large intergenic regions (IGRs) ranging from 50 to 197 bp
and with no obvious nucleotide homology to each other (see
Fig. S1I in the supplemental material for PUL schematics). A pre-
vious study in which polar insertions were made in anti- coding
genes suggested that these genes are cotranscribed (5), and we
confirmed this for one PUL (BT4636-31) where the genes flanking
a 129-bp region could be detected within a single transcript by
reverse transcription-PCR (RT-PCR) (Fig. S7F). On the basis of
these observations, we hypothesized that these IGRs play a role in
O-glycan repression. To test this, we deleted 118 bp (leaving an
11-bp ribosome binding sequence [RBS]) at the 5= end of the
cotranscribed IGR in BT4636-31 PUL that is consistently re-
pressed by alternative glycans (Fig. 4A). Deletion of this region in
a mutant strain (BT4635-34 IGR mutant) had no effect on
downstream susC-like gene expression when PMOGwas the only
carbon source, indicating that it does not harbor a required pro-
moter or other sequence required for activation (Fig. 4B). How-
ever, when this mutant was grown in either a levan and PMOG
mix (Fig. 4C) or pregrown to mid-exponential phase on PMOG
and then introduced to levan (Fig. 4D), expression of the down-
stream BT4634 transcript escaped normal repression. In fact, it
was significantly upregulated during early growth phase in batch
culture. Deletion of this particular IGR had no effect on the ex-
pression patterns of the six other PMOG PULs (Fig. 4C), indicat-
ing that its effect is largely autonomous and restricted to the cis-
encoded genes that flank it. Despite this discordant PUL
expression, both wild-type and BT4635-34 IGR strains had sim-
ilar growth profiles on PMOG alone (Fig. S7G). Taken together,
these data suggest that the BT4636-31 O-glycan PUL contains its
own cis-encoded sequence through which repression is mediated
at either theDNAormRNA level, a phenomenon thatmay extend
to PULs specific for other polysaccharides and in other species.
To determine whether the 129-bp BT4635-34 IGR was suffi-
cient to cause repression of genes with which it is genomically and
transcriptionally associated, we used the BT4635-34 IGR strain
that lacks this sequence in its native PUL as a background and
made two genomic constructs in which a Bacteroides-adapted gfp
reporter gene (Fig. 4E) was fused downstream of a constitutively
expressed, candidate nonessential (34) B. thetaiotaomicron gene,
BT0658. In previous microarray experiments (6, 7, 12), this gene
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was expressed, across multiple in vitro and in vivo conditions, to
levels similar to those of genes in the BT4635-31 transcript during
growth on PMOG as the sole carbon source. The two different
reporter strains varied only with respect to inclusion of the full
IGR between BT0658 and the downstream gfp allele, with one
strain containing only the 11-bp RBS sequence that was left be-
hind in the BT4635-34 strain (Fig. 4E). Using this approach, we
were able to determine whether the BT4635-34 IGR contained
all of the sequence required for orchestrating repression of its
nativeO-glycan-responsive PUL. Results from a batch culture ex-
periment with levan and PMOG as the combined carbon sources
showed similar gfp transcript levels between strains, regardless of
whether they contained the full IGR sequence (Fig. 4F). As inter-
nal controls for the anticipated repressive environment, expres-
sion of PUL genes involved in degrading levan (BT1763, priori-
tized) and O-glycans (BT4634 and BT4134) was measured and
behaved as expected (note that the background strain in this ex-
periment lacks the 118-bp IGR upstream of BT4634, which is why
this gene does not show normal repression). Thus, this observa-
tion implies that although the 129-bp IGR that lies upstream of
BT4634 is necessary for PUL repression when higher priority nu-
trients are present, this sequence is not sufficient for this function.
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It is therefore likely that sequences contained in the flanking
anti- and/or susC-like genes are required, and future experi-
ments will focus on defining these sequences. Toward this point, it
is worth noting that, while we observe conditional repression of
the susC-like gene (BT4634) and other downstream open reading
frames (ORFs) in this and other O-glycan PULs, the upstream
anti- gene (BT4635) was not subject to the same growth phase-
specific repression (see Fig. S7H in the supplemental material).
Provided the insight reported here regarding the role of the inter-
vening IGR in PUL repression, it is probable that this region is the
point at which PUL transcript is destabilized by an unknown
mechanism and that this event does not equally influence the up-
stream anti- gene.
DISCUSSION
Many bacteria that thrive in complex nutrient environments are
capable of utilizing several different substrates. Suchmicroorgan-
isms are often programmed to give preference to certain com-
pounds either because they represent higher energetic value or
because they are more easily or consistently accessed. We have
previously reported that B. thetaiotaomicron exhibits preferential
metabolism of some of the 12 different glycans that it can de-
grade and placesO-glycans low in this hierarchy when all are pres-
ent together (26). Data presented here extend this finding to
nearly all single glycan sources accessible to B. thetaiotaomicron as
well as simple sugars. A possible explanation for this behavior is
the cost of degrading the ~102 different glycan structures present
on mucins. B. thetaiotaomicron activates expression of 86 genes
10-fold during growth in PMOG (6). In contrast, activation of
only five genes is sufficient (7) to catabolize the simpler and highly
prioritized dietary glycan, pectic galactan (Fig. 1L). Indeed, one
reason why animals create such diverse O-glycan structures at-
tached tomucinsmay be to complicate the degradation process of
these barriermolecules bymicroorganisms in order to retain their
protective capacity. Given this scenario, it is possible that some
bacteria have adapted as specialists for mucin degradation, per-
haps by optimizing enzymatic strategies forO-glycan deconstruc-
tion or focusing on the dominant, and therefore most economical
to harvest, sugars and linkages that are present. B.massiliensis and
B. fragilis appear to be exhibiting a tendency toward specialization
formucinO-glycan degradation, since they utilize only one glycan
or two additional glycans, respectively. More strikingly, B.massil-
iensis has even restricted the repertoire of simple sugars that it can
metabolize to those found in O-glycans. B. massiliensis shows
mostly reciprocal preference for O-glycans relative to B.
thetaiotaomicronwhen grown on starch, suggesting that it has fur-
ther optimized its preference for host mucin glycans over dietary
substrates.
Collectively, our results provide several new lines of insight
into the phenomenon and mechanism of PUL repression in Bac-
teroides. In addition to showing for the first time that individual
species can prioritize nutrient mixtures differently, we also delin-
eate part of the pathway through which alternative carbohydrate
signals modulate individual PULs and explain variation in PUL
expression during growth in mixed nutrients (see Fig. 5 for a
working model). On the basis of our experiments with chimeric
O-glycan PULs that respond to similar O-glycan cues (Fig. 3), we
conclude that substrate sensing is a paramount first step that can
vary between PULs in the context of the particular suite of nutri-
ents that are present. This is especially important with mucin
O-glycans that contain many dozen related but variable struc-
tures, some of which may harbor critical cues, such as LacNAc
disaccharide, within larger chains and are potentially occluded by
other surrounding linkages.
When substrate is successfully recognized and degraded, the
released monosaccharides, which vary in identity based on the
particular glycans present, flow into the cell where they can be
sensed by an unknown mechanism, and this information is re-
layed to individual PULs to modulate their expression. Experi-
ments with one IGR (Fig. 4) imply that this regulatorymechanism
requires this region at either theDNAormRNA level to reduce the
abundance of low-priority PUL transcripts. While the complete
molecular mechanism through which PUL repression occurs is
not elucidated here, it is clear that individual PULs are capable of
exhibiting variable responses to different carbohydrates, both
with respect to the identity of the alternative glycan (Fig. 1; see Fig.
S1 in the supplemental material) or the identity of monosaccha-
rides and timing of the response (Fig. S2). For example, genes
within the BT4636-31 PUL are repressed in the presence of several
chemically distinct glycans (levan, chondroitin sulfate, amylopec-
tin, etc.), but not in the presence of heparin, which imposes re-
pression of other PULs in the same bacterial population sampled
(Fig. S1A). In contrast, the PUL containing BT4247 is repressed
under the same conditions listed for BT4636-31, including hepa-
rin, but escapes repression during growth in arabinan, a glycan
that imposes strong repression on BT4634 (Fig. S1H). Decipher-
ing how multiple, chemically distinct signals are integrated into
regulation of each individual PUL and also distinguished from
one another to create discordant regulatory effects at different
PULs will illuminate a key area of global gene regulation in this
diverse phylum of important gut symbionts.
Consistent with substrate sensing (i.e., transcriptional activa-
tion via glycan cues that may be present but masked by other
linkages) being dominant relative to transcription repression in
mediating sequential expression of PULs, an additional experi-
ment using the 100 mM fraction as a growth substrate and wild-
type and BT4635-34 IGR B. thetaiotaomicron strains revealed
that growth phase-specific repression of BT4634 was only par-
tially, yet still significantly (P 0.0007), alleviated with IGR dele-
tion (Fig. 5, inset). Growth phase-specific deployment of the
BT4634 PUL is not governed by the identity of its promoter and
regulatory elements, or even its IGR, but instead tracks with the
portion of the gene encoding its SusC-like transporter and down-
stream enzymatic functions involved in recognizing an unknown
host glycan structure (Fig. 3C). Thus, we conclude that eliminat-
ing IGR-mediated repression of this PUL in this particular sub-
strate mixture results in modest loss of repression because its in-
ducing substrate may still not be revealed until later in growth.
Prerequisite processing steps (shown as gray sugars attached to the
blue inducing saccharide in Fig. 5) may therefore be required to
fully activate this system, even in the absence of IGR-mediated
repression, and these steps could be conferred by the action of the
several additional O-glycan-responsive PULs in B. thetaiotaomi-
cron.
Our finding that many different simple sugars exert repression
of B. thetaiotaomicron O-glycan PULs adds to a previous conclu-
sion by Lynch and Sonnenburg (27), where despite reporting that
one monosaccharide (fructose) represses expression of a single
PUL involved in arabinan utilization, they concluded that activa-
tion of the transcriptional regulator associated with arabinan-
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dependent gene expression is responsible for repression of three
genomically unlinkedO-glycan PULs (two of which are alsomon-
itored here and shown to be repressed). In this case, the natural
ligand for the causative transcriptional regulator is known to be
arabinan oligosaccharide and not arabinose (7), suggesting that
this oligosaccharide cue signals repression of PULs involved in
utilizing O-glycans and other substrates. A potential confounder
in interpreting these data is that fructose was used via exposure to
a chimeric hybrid two-component system regulator that sensed
thismonosaccharide and activated genes involved in arabinan uti-
lization. While this hybrid regulator was expressed in a B.
thetaiotaomicron mutant that was impaired for fructose uptake
andmetabolism, it was still capable of substantial growth on fruc-
tose (28), making it unclear whether the monosaccharide could
have also had a direct effect. Nevertheless, these data collectively
indicate that multiple mechanisms may be at work to fine-tune
global expression of B. thetaiotaomicron glycan utilization func-
tions in complex nutrient environments.
Understanding the complex metabolic relationships between
dietary and mucosal glycans in the behavior of symbiotic gut bac-
teria will undoubtedly illuminate new aspects of how the gut mi-
crobiota contributes to health and disease. For example, several
PULs shown here and in previous work (6) to be repressed by
alternative nutrients harbor sulfatase-encoding genes. We have
recently shown that sulfatases are required by B. thetaiotaomicron
to cause inflammation in susceptible mice (24). If knowledge of
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diet or prebiotic nutrient conditions can be leveraged to suppress
expression of these harmful pathways, itmay be possible to reduce
or eliminate their contribution to disease states.
Given the vast number of microbial lineages that compose the
human gut microbiota and the often large number of different
carbohydrate and other nutrient utilization traits encoded in in-
dividual species, it is likely that many additional metabolic rela-
tionships exist like those described in this report. Indeed, if addi-
tional opposing preferences for carbohydrate utilization exist
among other gut microorganisms, these behaviors could be a ma-
jor and unappreciated determinant of how different microbes ex-
ecute their metabolic potential in vivo (35). Understanding these
behaviors and their underlyingmechanisms will be critical to pre-
dicting the behavior and assembly of human gut microbial com-
munities during health and disease and designing therapeutic in-
terventions.
MATERIALS AND METHODS
Growth and genetic manipulation of Bacteroides. The type strains Bac-
teroides thetaiotaomicron ATCC 29148 (VPI 5482), Bacteroides massilien-
sis B84634 (DSM17679), and Bacteroides fragilis ATCC 25285
(NCTC9343) were used for all experiments except those in Fig. S4 in the
supplemental material. Growth profiles and nearly all early/late gene ex-
pression experiments were performed using the same conditions and car-
bons sources as previously described (7), except when noted. B.
thetaiotaomicron was pregrown in TYG broth overnight at 37°C in an
anaerobic chamber (Coy Lab Products) under an 85% N/10% H2/5%
CO2 atmosphere for all experiments. B. fragilis and B. massiliensis were
pregrown in a custom chopped-meat (CM) broth under the same condi-
tions (36). Prior to any growth or transcript expression experiments, allB.
thetaiotaomicron and B. fragilis strains, including B. thetaiotaomicron
strains that are not the type strain in Fig. S4, were transferred to minimal
medium with glucose (MM-G) for overnight growth. When initially
growingB.massiliensis inminimalmedium,we discovered that it is some-
what fastidious. First, it was unable to grow on glucose alone so we used
N-acetylglucosamine (GlcNAc) as a carbon source. Second, the addition
of the supplements enhanced growth onminimalmedium. Thus, we grew
this strain in minimal medium containing Balch’s vitamins, trace miner-
als, amino acids, purine/pyrimidines, and beef extract (final concentra-
tion of 0.5mg/ml) also found in our customCMbroth.We then tested for
growth on these additionalmedium components usingwater as a negative
control and GlcNAc as a positive control. We determined that B. massil-
iensis does not have the ability to grow on these substances alone. All
strains were then washed in 2 concentration minimal medium with no
carbon (MM-NC) prior to conducting any experiment with one source of
carbon, glycanmixes, or alternative glycan introductions (spike-in exper-
iments).
All growth curves, except where noted below, were performed in
200-l cultures in 96-well microtiter plates and a robotic plate stacking
and handling device (BioTek) (7). All growth curves were performed at
37°C except that B. thetaiotaomicron titration curves from Fig. S1 in the
supplemental material were performed at 30°C to help accent the diauxic
shift and help determine where harvest points for early and late time
points were based on the substrate (three replicate cultures for each mix-
ture ratio; run on separate 96-well plates). However, at 37°C, B.
thetaiotaomicron behaved similarly when samples were taken for expres-
sion profiles. We determined that B. fragilis and B. massiliensis have lim-
ited glycan-degrading capabilities, under the conditions tested, by grow-
ing themon a customglycan array in the same 200-l culture robotic plate
stacking and handling device. All spike-in, RNA-Seq, and 100 mM frac-
tion cell harvests as well as B.massiliensis starch/porcinemucinO-glycans
(PMOG) growth curves were performed in glass tubes using a UV-visible
(UV-Vis) spectrophotometer (Thermo) tomonitor absorbance at 600 nm
(A600).B. thetaiotaomicronmutants and chimeric PUL recombinantswere
prepared by allelic exchange as previously described (28).
Transcript measurements by qPCR and whole-genome transcrip-
tional profiling by RNAseq. For each glycan mixture tested at early and
late time points, three replicate culture sets were assayed. For B.
thetaiotaomicron and B. fragilis, all glycan mixes tested were 1.5 mg/ml
non-PMOG and 7 mg/ml PMOG (or human milk oligosaccharides
[HMOs]) except for rhamnogalacturonan I (RG I) that was used at 3
mg/ml combined with 7 mg/ml PMOG. For B. massiliensis, a mixture of
7 mg/ml amylopectin from potato (APpot) and 1.5 mg/ml PMOG was
used for cell harvests. To provide sufficient RNA for analysis, a total of 12
replicate 200-ml cultures were combined into a single 2.4-ml sample rep-
resenting a series of slightly different harvest points. Thus, the sampling
points shown in Fig. S1 in the supplemental material are shown as a
distribution of 12 different A600 values and their corresponding average.
For B.massiliensis early and two late glycan-specific PUL transcripts, cells
were grown in glass tubes to keep consistentwith initial glycanmix growth
curves.
To measure spike-in glycan-specific PUL transcripts, B. thetaiotaomi-
cron was grown in triplicate under 37°C conditions as described above.
Cells were grown on 10 mg/ml minimal medium with PMOG (MM-
PMOG) in glass tubes to mid-exponential phase, and the cells were har-
vested at time zero (T0). Then, either MM-levan, MM-HG (minimal me-
dium with homogalacturonan), MM-polysaccharide mix (2.5 mg/ml
final), orMM-NCwas introduced to theMM-PMOGculture. The culture
was then allowed to incubate for 2 h while harvesting cells every 30 min.
All harvested cells were treated with RNAprotect bacterial reagent (Qia-
gen) and stored at	80°C until processed. Total RNA was extracted from
cells using anRNeasy kit (Qiagen), treatedwith TurboDNase I (Ambion),
and reverse transcribed using Superscript III (Invitrogen). The 16S rRNA
gene-normalized PUL gene abundance was assayed on an Eppendorf Re-
alplex thermocycler and using SYBR FAST premixed qPCR master mix
(Kapa Biosystems). All cultures assayed were actively growing on one or
more carbon sources, and the use of 16S rRNA gene normalization is
rationalized based on extensive comparisons of qPCRmeasurements with
microarray or RNAseq data that were normalized using other algorithms
that were not based on 16S rRNA genes (for example, Fig. 3C) (6, 7).
For RNAseq, the total RNA from B. fragilis and B. massiliensis cells
grownonPMOGwith glucose andGlcNAc, respectively, used as reference
comparisons, was extracted using an RNeasy kit (Qiagen) and treated
with Turbo DNase I (Ambion), and finally, rRNA was depleted using the
Bacteria Ribo-Zero rRNA removal kit (Epicentre). Residual mRNA was
converted to sequencing libraries using TruSeq barcoded adaptors (Illu-
mina) and sequenced at theUniversity ofMichigan SequencingCore in an
Illumina HiSeq instrument with 24 samples multiplexed per lane. Bar-
coded data were demultiplexed and analyzed using the Arraystar software
package with Qseq (DNAstar).
Illumina RNA sequencing data. Sequencing data were deposited in
NCBI under SRA accession numbers SRP035212 and SRP063781.
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